Research programme: cyclin-dependant kinases - Virostatics

Drug Profile

Research programme: cyclin-dependant kinases - Virostatics

Alternative Names: VS2 370

Latest Information Update: 30 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Virostatics
  • Class Antineoplastics; Antivirals; Small molecules
  • Mechanism of Action Cyclin dependent kinase 9 inhibitors; Cyclin-dependent kinase 4 inhibitors; Cyclin-dependent kinase 6 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Cancer; HIV infections
  • Research Epstein-Barr virus infections; Hepatitis B; Varicella zoster virus infections
  • Discontinued Ebola virus infections; Herpes simplex virus type 1 infections; Herpes simplex virus type 2 infections; Human papillomavirus infections

Most Recent Events

  • 30 Jun 2017 Discontinued for Ebola virus infections in Italy (PO) as the indication is not listed on the pipeline (Virostatics pipeline, June 2017)
  • 30 Jun 2017 Discontinued for Herpes simplex virus type-1 infections in Italy (PO) as the indication is not listed on the pipeline (Virostatics pipeline, June 2017)
  • 30 Jun 2017 Discontinued for Herpes simplex virus type-2 infections in Italy (PO) as the indication is not listed on the pipeline (Virostatics pipeline, June 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top